Beacon Financial Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,248
Closed -$216K 360
2025
Q4
$216K Sell
4,248
-59
-1% -$3.02K 0.02% 332
2025
Q3
$239K Buy
4,307
+178
+4% +$10.4K 0.02% 322
2025
Q2
$285K Buy
4,129
+1,245
+43% +$84.7K 0.03% 291
2025
Q1
$200K Buy
2,884
+177
+7% +$14.6K 0.02% 330
2024
Q4
$233K Buy
2,707
+195
+8% +$21.1K 0.03% 310
2024
Q3
$299K Buy
2,512
+646
+35% +$86.2K 0.03% 283
2024
Q2
$266K Buy
1,866
+32
+2% +$4.24K 0.03% 284
2024
Q1
$235K Buy
+1,834
New +$218K 0.03% 298
2015
Q2
Sell
-29,168
Closed -$798K 175
2015
Q1
$798K Buy
29,168
+1,876
+7% +$43.2K 0.18% 81
2014
Q4
$582K Buy
27,292
+360
+1% +$8.04K 0.12% 108
2014
Q3
$651K Sell
26,932
-168
-0.6% -$3.87K 0.14% 102
2014
Q2
$622K Buy
27,100
+4,914
+22% +$108K 0.14% 100
2014
Q1
$501K Sell
22,186
-74
-0.3% -$1.58K 0.1% 119
2013
Q4
$411K Buy
22,260
+1,580
+8% +$27.5K 0.08% 141
2013
Q3
$351K Buy
+20,680
New +$348K 0.08% 140

Other funds holding NVO

Beacon Financial Group's NVO Position: Q1 2026 in Review

Beacon Financial Group sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 4,248 shares — an estimated $216K sold.

Beacon Financial Group first reported a position in NVO in Q3 2013 and held it in 15 quarters. The position peaked at $798K in Q1 2015. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Beacon Financial Group reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Beacon Financial Group sold 4,248 Novo Nordisk shares in Q1 2026, an estimated $216K.
  • Beacon Financial Group first reported a position in Novo Nordisk in Q3 2013 and held it in 15 quarters.
  • Beacon Financial Group's Novo Nordisk position peaked at $798K in Q1 2015.
  • 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Beacon Financial Group's 13F filing for Q1 2026, filed 30 Apr 2026.